Atlantic Investment Management Inc. Acquires New Holdings in Bath & Body Works, Inc. $BBWI

Atlantic Investment Management Inc. bought a new position in shares of Bath & Body Works, Inc. (NYSE:BBWI) during the 3rd quarter, according to its most recent filing with the Securities and Exchange Commission. The firm bought 150,000 shares of the company’s stock, valued at approximately $3,864,000. Bath & Body Works accounts for approximately 2.2% of Atlantic Investment Management Inc.’s holdings, making the stock its 11th largest holding. Atlantic Investment Management Inc. owned about 0.07% of Bath & Body Works at the end of the most recent quarter.

A number of other institutional investors have also recently added to or reduced their stakes in BBWI. Gabelli Funds LLC raised its stake in shares of Bath & Body Works by 1.2% during the third quarter. Gabelli Funds LLC now owns 47,536 shares of the company’s stock valued at $1,225,000 after acquiring an additional 542 shares during the last quarter. Sumitomo Mitsui Trust Group Inc. lifted its holdings in shares of Bath & Body Works by 3.7% during the third quarter. Sumitomo Mitsui Trust Group Inc. now owns 16,700 shares of the company’s stock worth $430,000 after purchasing an additional 600 shares during the period. State of Wyoming grew its stake in shares of Bath & Body Works by 6.2% in the second quarter. State of Wyoming now owns 11,294 shares of the company’s stock worth $338,000 after purchasing an additional 661 shares during the last quarter. Vident Advisory LLC grew its stake in shares of Bath & Body Works by 2.8% in the second quarter. Vident Advisory LLC now owns 25,229 shares of the company’s stock worth $756,000 after purchasing an additional 692 shares during the last quarter. Finally, Synovus Financial Corp increased its holdings in Bath & Body Works by 1.4% in the third quarter. Synovus Financial Corp now owns 56,210 shares of the company’s stock valued at $1,448,000 after purchasing an additional 764 shares during the period. 95.14% of the stock is owned by institutional investors.

Key Stories Impacting Bath & Body Works

Here are the key news stories impacting Bath & Body Works this week:

• Positive Sentiment: Bath & Body Works says it will offer fewer discounts in 2026, a deliberate move to protect gross margins and improve profitability if execution sustains. Article Title
• Positive Sentiment: Coverage notes a “major change customers will notice” (likely tied to merchandising/discounting strategy) that could lift average selling prices and margins. Investors often reward visibility on margin recovery. Article Title
• Positive Sentiment: Telsey Advisory raised BBWI’s price target to $25 while keeping a Market Perform rating — a signal that some analysts are modeling better margin outcomes even if the view remains cautious. Article Title
• Neutral Sentiment: Sector spotlight: Bath & Body Works was listed among consumer discretionary stocks worth watching, which can drive trading interest but is not a direct catalyst. Article Title
• Negative Sentiment: Numerous law firms (Rosen, Faruqi, Glancy, Pomerantz, Schall, Gross, Bernstein Liebhard, DJS, others) are soliciting Bath & Body Works investors about a securities‑fraud class action and urging lead‑plaintiff filings ahead of a March 16 deadline — increasing headline risk and the potential for costly litigation or settlement. Representative notice: Rosen Law Firm. Article Title
• Negative Sentiment: Additional plaintiff‑firm alerts increase the likelihood of consolidation into a lead plaintiff and amplify settlement/defense cost uncertainty; see Glancy/PR Newswire notices for more detail. Article Title

Bath & Body Works Stock Up 3.6%

Shares of Bath & Body Works stock opened at $19.46 on Friday. The company has a market cap of $3.98 billion, a PE ratio of 6.18, a price-to-earnings-growth ratio of 1.95 and a beta of 1.48. Bath & Body Works, Inc. has a 52 week low of $14.27 and a 52 week high of $34.66. The business has a 50 day moving average price of $22.37 and a 200-day moving average price of $23.10.

Bath & Body Works (NYSE:BBWI) last posted its earnings results on Wednesday, March 4th. The company reported $2.05 earnings per share for the quarter, beating analysts’ consensus estimates of $1.77 by $0.28. Bath & Body Works had a negative return on equity of 45.60% and a net margin of 8.90%.The company had revenue of $2.72 billion for the quarter, compared to analyst estimates of $2.59 billion. During the same quarter last year, the company earned $2.09 earnings per share. The company’s revenue for the quarter was down 2.3% on a year-over-year basis. Bath & Body Works has set its Q1 2026 guidance at 0.240-0.300 EPS and its FY 2026 guidance at 2.400-2.650 EPS. As a group, research analysts anticipate that Bath & Body Works, Inc. will post 3.3 EPS for the current year.

Bath & Body Works Dividend Announcement

The company also recently declared a quarterly dividend, which was paid on Friday, March 6th. Investors of record on Friday, February 20th were issued a dividend of $0.20 per share. The ex-dividend date was Friday, February 20th. This represents a $0.80 annualized dividend and a yield of 4.1%. Bath & Body Works’s payout ratio is 25.40%.

Wall Street Analyst Weigh In

Several research analysts recently issued reports on BBWI shares. Citigroup lowered Bath & Body Works from a “buy” rating to a “neutral” rating and raised their target price for the stock from $21.00 to $25.00 in a research report on Tuesday, February 17th. Bank of America set a $26.00 price target on Bath & Body Works in a research report on Monday, November 24th. The Goldman Sachs Group cut Bath & Body Works from a “buy” rating to a “neutral” rating and decreased their price target for the company from $39.00 to $17.00 in a research note on Thursday, November 20th. UBS Group raised their price objective on Bath & Body Works from $21.00 to $22.00 and gave the stock a “neutral” rating in a research report on Monday, February 23rd. Finally, Deutsche Bank Aktiengesellschaft lifted their price objective on Bath & Body Works from $21.00 to $22.00 and gave the stock a “hold” rating in a research note on Tuesday, March 3rd. Three equities research analysts have rated the stock with a Buy rating and fourteen have assigned a Hold rating to the stock. According to MarketBeat, the stock has an average rating of “Hold” and a consensus target price of $24.00.

Bath & Body Works Profile

Bath & Body Works, Inc is a leading specialty retailer focused on personal care, home fragrance and complementary products. Through its flagship Bath & Body Works brand, the company offers a diverse assortment of shower gels, lotions, fragrance mists, candles and home fragrance items. Its product portfolio also includes the White Barn Candle Co range of premium scented candles and diffusers. Bath & Body Works serves consumers through a combination of brick-and-mortar stores and e-commerce platforms, delivering seasonal collections, limited-edition releases and signature scent lines.

Founded in 1990 as part of Limited Brands (now L Brands), Bath & Body Works opened its first store in New Albany, Ohio, and quickly expanded across the United States.